Skip to main content
. 2008 Apr 7;14(13):2061–2064. doi: 10.3748/wjg.14.2061

Table 1.

Patient’s data and indications for CE: Group A (fasting) and group B (additionally Prepacol®)

Group A Group B P value
Gender (w/m) 13/13 10/16 NS
Age (yr) 54 ± 17 56 ± 20 NS
Weight (kg) 71 ± 15 79 ± 17 NS
Length (cm) 170 ± 10 171 ± 8 NS
Indication
GI-bleeding 17 (65%) 19 (73%) NS
Inflammatory bowel disease 4 (15%) 3 (12%) NS
Miscellaneous 5 (19%) 4 (15%) NS

Data are mean ± SEM; NS: Not significant.